Tocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: the diagnostic significance of interleukin-18 and interleukin-6 (Q83592010)
Jump to navigation
Jump to search
scientific article published on 06 March 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Tocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: the diagnostic significance of interleukin-18 and interleukin-6 |
scientific article published on 06 March 2012 |
Statements
Tocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: the diagnostic significance of interleukin-18 and interleukin-6 (English)
Masaki Shimizu
Yasuo Nakagishi
Kazuko Kasai
Yuichi Yamasaki
Mari Miyoshi
Syuji Takei
Akihiro Yachie